3 min read

Diverticular Treatment Market Outlook Highlights Strong Regional Opportunities

May 5

The <a href="mailto:https://www.transparencymarketresearch.com/north-america-diverticular-treatment-market.html">North America diverticular treatment market</a> was valued at US$ 986.6 million in 2022 and is projected to exceed US$ 1.9 billion by 2031, expanding at a CAGR of 7.6% from 2023 to 2031. Growth is driven by the rising prevalence of diverticular diseases, increasing aging population, and advancements in treatment options, along with improved healthcare infrastructure and awareness across the region.Surge in prevalence of diverticular diseases, rise in healthcare expenditure, and increase in awareness about the disease are driving North America diverticular treatment market demand. Surge in geriatric population in the region is another factor propelling market progress. Sedentary lifestyle, consumption of diet having low fiber, and intake of high processed foods are expected to bolster North America diverticular treatment market value.Dive Deeper into Data: Get Your In-Depth Sample Now! <a href="https://www.transparencymarketresearch.com/sample/sample.php?flag=S&amp;rep_id=85622">https://www.transparencymarketresearch.com/sample/sample.php?flag=S&amp;rep_id=85622</a> Increase in investment in development of advanced treatment options is projected to offer lucrative opportunities to market players. Post the COVID-19 pandemic, diverticular treatment companies are making data-driven decisions before investing in new products. They are investing significantly in the research and development of advanced diverticular treatment options.Key Findings of the Market Report<ul><li>Uncomplicated Diverticulitis is the fastest-growing segment (9.2% CAGR) as improved screening and awareness lead to earlier, non-surgical diagnoses.</li><li>CT Scans remain the gold standard and hold the largest share of the diagnostic segment, though ultrasound usage is increasing for bedside monitoring.</li><li>Medication is the fastest-growing treatment segment, shifting from broad-spectrum antibiotics toward targeted anti-inflammatory and microbiome-restoring agents.</li><li>Hospitals remain the primary end-user, but Specialty Clinics and ASCs are seeing a 12% annual increase in volume for elective laparoscopic procedures.</li></ul>Global Market: Growth Drivers<ul><li>Demographic Aging: Over 50% of the population over 60 years of age shows signs of diverticulosis, creating a massive potential patient pool.</li><li>Dietary and Lifestyle Shifts: High consumption of processed foods and rising rates of sedentary behavior continue to drive disease incidence.</li><li>Minimally Invasive Advancements: Robotic and laparoscopic systems have reduced the "fear factor" of surgery, leading to more elective, preventive resections.</li><li>Emerging Targeted Therapies: Development of first-in-class, disease-modifying drugs aims to address the underlying causes of inflammation rather than just the infection.</li></ul>Global Market: Key PlayersThe North American market is led by pharmaceutical giants and specialized MedTech firms providing the surgical hardware used in resections.<ul><li>Pfizer Inc.</li><li>Johnson & Johnson (MedTech and Pharmaceutical divisions)</li><li>Merck & Co., Inc.</li><li>AbbVie Inc.</li><li>Bayer AG</li><li>GlaxoSmithKline plc</li><li>Takeda Pharmaceutical Company Limited</li><li>Intuitive Surgical, Inc. (Robotic hardware leader)</li><li>Stryker Corporation</li><li>Novartis AG</li></ul>Global Market: SegmentationBy Type<ul><li>Uncomplicated Diverticulitis (Fastest Growth)</li><li>Complicated Diverticulitis (Largest Revenue Share)</li></ul>By Diagnosis<ul><li>Computed Tomography (CT) Scan (Dominant)</li><li>Ultrasound & X-ray</li><li>Colonoscopy (Secondary/Follow-up)</li><li>Blood & Urine Tests</li></ul>By Treatment<ul><li>Medications (Antibiotics, Anti-inflammatories)</li><li>Surgery (Laparoscopic, Robotic, Open Colectomy)</li><li>Supportive Care (Dietary Supplements, IV Fluids)</li></ul>By End-User<ul><li>Hospitals</li><li>Ambulatory Surgical Centers (ASCs)</li><li>Specialty Clinics & Research Institutes</li></ul>Buy this Premium Research Report: <a href="https://www.transparencymarketresearch.com/checkout.php?rep_id=85622&amp;ltype=S">https://www.transparencymarketresearch.com/checkout.php?rep_id=85622&amp;ltype=S</a> About Transparency Market ResearchTransparency Market Research, a global <a href="https://www.globenewswire.com/Tracker?data=MKyRdE0P94ioyU9f_0pp_wK0uV5-pktG40_qdemb39yORO5ij1UiDsjS3kZVPgI-OU0u348INknIe5Axs0iEQkizjjMb2WGH24rFxKRmG66df6VI3JqcmmcboAodjufF">market research company</a> registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.Contact:Abhishek Budholiya Transparency Market Research Inc. State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: <a href="https://www.transparencymarketresearch.com">https://www.transparencymarketresearch.com</a> Sales Inquiries: sales@transparencymarketresearch.com Media Inquiries: <a href="mailto:media@transparencymarketresearch.com">media@transparencymarketresearch.com</a>

Comments

Join the conversationSign in to comment